Prednisone in Adults With an Immune-Mediated Subtype of Autism Spectrum Disorder
NCT06934915
Autism, Autism Spectrum Disorder
Lexington, Massachusetts, United States
View Trial DetailsNCT Number: NCT07159113
The aim of this study was to investigate the relationship between sensory profile and ankle muscle shortness in children with autism.
This study will feature only one group consisting of children with autism
Childhood autism assessment scale will be completed with the families of the children included in the study. The tip-toe walking status of the children participating in the study will be observed and classified according to the tip-toe walking classification. The ankle muscle shortness of the children will be evaluated by Gastro-Soleus shortness measurements and sensory processing skills will be evaluated by Sensory profile.
Muscle shortness measurements and sensory profile results will be compared.
Trial opening soon.
Get Notified4 year–10 year
All sexes
Observational
Bolu Abant İzzet Baysal University, Bolu, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: One year
This test is used to assess how children aged 3-10 years process information from their body and environment. It is a five-point Likert-type parent questionnaire and consists of 125 items. It is explained to the caregiver that he/she should check the box that best describes how often the child performs the behaviors given in the questionnaire and answer for all parameters; if he/she cannot answer because there is a behavior that he/she cannot observe at all or that he/she thinks does not fit the child, he/she should put an X on that question.
The end of each section is scored according "always" 1, "frequently" 2, "occasionally" 3, "rarely" 4, "never" 5. The scores obtained from each parameter are calculated according to the Dunn Sensory Profile Score Explanation and the child is classified according to the categories of 'definite difference', 'probable difference', 'typical performance' from each section.
Time frame: One year
It is a scale consisting of 15 items used to assess the severity of autism, with each item scored between 1 and 4. A score of 1 represents that the child's behavior for that item is normal for his/her age, while a score of 4 represents that it is extremely abnormal. The minimum score is 15 and the maximum score is 60. The results are evaluated as "no autism" between 15-29 points, "mild-moderate autism" between 30-36 points, and extreme autism between 37-60 points. Families of the children were asked to fill out the froms.
Time frame: One year
Passive foot dorsiflexion measurement with a manual goniometer was performed at 0 degrees knee flexion for Gastrocnemius muscle and 90 degrees knee flexion for Soleus muscle. Muscle shortness was expressed in degrees. Ankle neutral position was recorded as 0 degrees, dorsiflexion angles as positive and plantar flexion angles as negative.
Time frame: One year
Tiptoe walking was assessed and classified by observation during 10-meter walk-run. Level 1 indicates that there is tiptoe behavior during running, walking and standing; Level 2 indicates that there is tiptoe behavior during running and walking; Level 3 indicates that there is tiptoe behavior only during running; if no tiptoe walking is observed, it was indicated as "no tiptoe walking".
Contact information is provided by the study sponsor or research team.
Abant Izzet Baysal University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06934915
Autism, Autism Spectrum Disorder
Lexington, Massachusetts, United States
View Trial DetailsNCT07522190
Autism, Autism Spectrum Disorder
Palo Alto, California, United States
View Trial DetailsNCT07661823
ADHD, ADHD - Attention Deficit Disorder With Hyperactivity
Richmond, Virginia, United States
View Trial DetailsNCT07673172
Adverse Childhood Experience, Autism
View Trial Details